A noninvasive method for identifying coronary dysfunction utilizing electrocardiography derived data
CA 2209761 A1 · Owner: Seegobin, Ronald · Inventors: Seegobin, Ronald
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of analyzing experimentally derived electrocardiograph (ECG) data, and system for practicing said method, which allow tracking of subject cardiac status change and which allow surprisingly accurate catagorization of subjects into various abnormal and normal classifications is disclosed. The presently preferred embodiment of the present invention applies an algorithm which compares representative parameter, (eg. root-mean-square (RMS) mean), values derived from analysis of a representative composite of selected portions of a number of ECG PQRST waveforms obtained from (ECG3) investigation of a subject, to similarly derived representative parameter, (eg. RMS mean and RMS standard …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 7, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 7, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 7, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.